210 related articles for article (PubMed ID: 16879968)
21. Highly antiproliferative, low-calcemic, side-chain ketone analogs of the hormone 1alpha,25-dihydroxyvitamin D3.
Posner GH; Kim HJ; Kahraman M; Jeon HB; Suh BC; Li H; Dolan P; Kensler TW
Bioorg Med Chem; 2005 Oct; 13(19):5569-80. PubMed ID: 16039132
[TBL] [Abstract][Full Text] [Related]
22. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
Arai MA; Kittaka A
Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
[TBL] [Abstract][Full Text] [Related]
23. Novel vitamin D3 antipsoriatic antedrugs: 16-En-22-oxa-1alpha,25-(OH)2D3 analogs.
Shimizu K; Kawase A; Haneishi T; Kato Y; Kobayashi T; Sekiguchi N; Yamamoto T; Ishigai M; Tokuda K; Matsushita T; Shimaoka S; Morikawa K
Bioorg Med Chem; 2006 Mar; 14(6):1838-50. PubMed ID: 16307885
[TBL] [Abstract][Full Text] [Related]
24. Isolation and identification of 2alpha,25-dihydroxyvitamin D3, a new metabolite from Pseudonocardia autotrophica 100U-19 cells incubated with Vitamin D3.
Takeda K; Kominato K; Sugita A; Iwasaki Y; Shimazaki M; Shimizu M
Steroids; 2006 Aug; 71(8):736-44. PubMed ID: 16784761
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
Verlinden L; Verstuyf A; Eelen G; Bouillon R; Ordóñez-Morán P; Larriba MJ; Muñoz A; Rochel N; Sato Y; Moras D; Maestro M; Seoane S; Dominguez F; Eduardo-Canosa S; Nicoletti D; Moman E; Mouriño A
ChemMedChem; 2011 May; 6(5):788-93. PubMed ID: 21520419
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist.
Cho K; Uneuchi F; Kato-Nakamura Y; Namekawa J; Ishizuka S; Takenouchi K; Nagasawa K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4287-90. PubMed ID: 18635349
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of new 6-s-cis locked 1,2,25-trihydroxyprevitamin D3 analogues.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Ferrero M; Gotor V
Bioorg Med Chem; 2007 Jun; 15(12):4193-202. PubMed ID: 17412598
[TBL] [Abstract][Full Text] [Related]
28. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications.
Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H
Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1alpha,25-dihydroxyvitamin D3: chemical synthesis and biological evaluation.
Usera AR; Dolan PM; Kensler TW; Posner GH
Bioorg Med Chem; 2007 Aug; 15(16):5509-18. PubMed ID: 17560112
[TBL] [Abstract][Full Text] [Related]
31. Novel synthetic approach to 1alpha,25-dihydroxyvitamin D3 and analogues.
Maestro M; Gómez-Reino C; Nicoletti D; Sigüeiro R; Fraga R; Ghini A; Torneiro M; Mouriño A
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):231-4. PubMed ID: 17254774
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues.
Schepens W; Van Haver DV; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
Bioorg Med Chem Lett; 2004 Aug; 14(15):3889-92. PubMed ID: 15225691
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D(3) analogues hydroxymethylated at C-26.
Regueira MA; Samanta S; Malloy PJ; Ordonez-Moran P; Resende D; Sussman F; Munoz A; Mourino A; Feldman D; Torneiro M
J Med Chem; 2011 Jun; 54(11):3950-62. PubMed ID: 21524075
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationship of p-carborane-based non-secosteroidal vitamin D analogs.
Fujii S; Kano A; Songkram C; Masuno H; Taoda Y; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem; 2014 Feb; 22(4):1227-35. PubMed ID: 24486205
[TBL] [Abstract][Full Text] [Related]
37. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
38. Highly potent vitamin D receptor antagonists: design, synthesis, and biological evaluation.
Saito N; Kittaka A
Chembiochem; 2006 Oct; 7(10):1479-90. PubMed ID: 16871612
[TBL] [Abstract][Full Text] [Related]
39. Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure.
Yamada S; Yamamoto K; Masuno H; Ohta M
J Med Chem; 1998 Apr; 41(9):1467-75. PubMed ID: 9554880
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of two C-7 methyl analogues of vitamin D.
Sokolowska K; Carballa D; Seoane S; Pérez-Fernández R; Mouriño A; Sicinski RR
J Org Chem; 2015 Jan; 80(1):165-73. PubMed ID: 25396296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
